UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034071
Receipt number R000038823
Scientific Title Effect of peripheral nerve block on post-operative delirium and post-operative cognitive dysfunction following total hip arthroplasty in elderly patients.
Date of disclosure of the study information 2018/09/09
Last modified on 2020/05/20 13:16:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of peripheral nerve block on post-operative delirium and post-operative cognitive dysfunction following total hip arthroplasty in elderly patients.

Acronym

Effect of PNB on POD and POCD following total hip arthroplasty in elderly patients.

Scientific Title

Effect of peripheral nerve block on post-operative delirium and post-operative cognitive dysfunction following total hip arthroplasty in elderly patients.

Scientific Title:Acronym

Effect of PNB on POD and POCD following total hip arthroplasty in elderly patients.

Region

Japan


Condition

Condition

Patients aged over 60 who undergo total hip arthroplasty under general anesthesia.

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to investigate the effectiveness of fascia iliaca block for prevention of postoperative delirium and post-operative cognitive dysfunction.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The occurrence of post-operative delirium and post-operative cognitive dysfunction.

Key secondary outcomes

intra-operative opioid dose
intraoperative Patient Status Index (PSI) and Spectral Edge Freguency (SEF), Surpression Rate (SR), Local Oximetry (rSO 2)
postoperative pain level on Day1 and Day 2
Frequency of use of PCA
use of auxiliary analgesics
occurrence of side effects by opioid (nausea / vomiting, dizziness, respiratory depression etc)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Fascia iliaca block

Interventions/Control_2

No therapy

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who will undergo total hip arthroplasty under general anesthesia.

Key exclusion criteria

1) Patients who are impaired in perception and difficult to undergo cognitive function tests.
2) Patients who can not complete the cognitive function tests.
3) Patients who have neurological disorders.
4) Patients who have mental illness.
5) Patients who have coagulopathy.
6) Patients who have history of cardiac surgery (open heart surgery) and brain surgery.
7) Patients who have alcoholism and drug addiction.
8) Patients who are allergic to local anesthetic.
9) Patients who judged inappropriate by research doctor.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Maiko Hosokawa

Organization

Showa university

Division name

Department of Anesthesiology

Zip code


Address

1-5-8 Hatanodai, Shinagawa-ku, Tokyo

TEL

03-3784-8575

Email

maiko-hskw@med.showa-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Maiko Hosokawa

Organization

Showa university

Division name

Department of Anesthesiology

Zip code


Address

1-5-8 Hatanodai, Shinagawa-ku, Tokyo

TEL

03-3784-8575

Homepage URL


Email

maiko-hskw@med.showa-u.ac.jp


Sponsor or person

Institute

Showa university

Institute

Department

Personal name



Funding Source

Organization

Showa university

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 09 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2018 Year 09 Month 04 Day

Date of IRB

2018 Year 07 Month 25 Day

Anticipated trial start date

2018 Year 09 Month 10 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 09 Month 09 Day

Last modified on

2020 Year 05 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038823


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name